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Oxidative stress and kidney dysfunction due to ischemia/reper-
fusion in rat: Attenuation by dehydroepiandrosterone.
Background. The pathogenesis of ischemia/reperfusion (I/R)
involves generation of reactive oxygen and nitrogen species.
This in vivo study investigates the effect of dehydroepiandro-
sterone (DHEA), a physiologic steroid with antioxidant prop-
erties, on oxidative balance and renal dysfunctions induced by
monolateral I/R.
Methods. Normal and DHEA-treated rats (4 mg/day  21
days, orally) were subjected to monolateral renal I/R (30 min-
utes/6 hours). The oxidative state was determined by measuring
hydrogen peroxide level and activities of glutathione-peroxi-
dase, catalase, and superoxide dismutase. Tumor necrosis factor-
(TNF-) and nitric oxide production and inducible nitric oxide
synthase (iNOS) levels were also measured. Hydroxynonenal
content was used to probe lipid peroxidation. Functional pa-
rameters determined were creatinine levels and Na/K-ATPase
activity. Immunohistochemical and morphologic studies were
also performed.
Results. A markedly pro-oxidant state was evident in the
kidney of rats subjected to I/R. Both hydrogen peroxide and
reactive nitrogen species (nitric oxide and iNOS) increased,
whereas antioxidants decreased. Oxidant species induce TNF-
increase, which, in turn, produces lipoperoxidative processes,
as documented by the increased hydroxynonenal (HNE) level.
As final result, impaired renal functionality, hydropic degener-
ation, and vacuolization of proximal convolute tubules were
observed in kidneys of I/R rats. DHEA pretreatment improved
the parameters considered.
Conclusion. I/R induces oxidative stress and consequently
damages the proximal convolute renal tubules. Rats supple-
mented with DHEA and subjected to I/R had reduced pro-
oxidant state, oxidative damage, and improved renal functionality,
indicating an attenuation of oxidative injury and dysfunctions
mediated by I/R.
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Ischemia/reperfusion (I/R) is an important cause of
organ dysfunction often leading to acute kidney failure,
causing high mortality among patients in intensive care
who require dialysis [1]. The severity of the injury depends
on the duration of ischemia and subsequent reperfusion.
Reperfusion, although essential for the survival of isch-
emic renal tissue, causes additional damage. Oxidative
stress is involved in kidney injury induced by I/R [2, 3].
Increased reactive oxygen species (ROS) generation oc-
curs after reperfusion, leading to oxidative damage and
dysfunction [4, 5]. Different experimental models have
shown that antioxidant therapy can protect against oxi-
dative damage induced by I/R [6, 7]. This protective
effect may be related to the ability of antioxidant com-
pounds to normalize early intracellular events linked to
the progression of oxidative damage [8, 9].
A number of mechanisms explain tissue I/R injury. In
addition to reduced glomerular filtration and accumula-
tion of leukocytes [10], ROS, reactive nitrogen species
(RNS) generation, and the loss of antioxidant defense
are also considered to play key roles. Many of these reac-
tive molecules activate the signaling mechanisms that cul-
minate in tumor necrosis factor (TNF) production [11].
TNF- is a proinflammatory cytokine capable of up-
regulating its own expression, as well as the expression
of other genes important in the inflammatory response
[12]. TNF-, lipopolysaccharides, and I/R increase induc-
ible nitric oxide synthase (iNOS) activity to synthetize
nitric oxide [13, 14]. Nitric oxide production may play
several roles in renal pathophysiology, including induc-
tion of tubular damage. Prevention or reduction of nitric
oxide generation reduces nitric oxide renal injury [15],
and the increased generation of nitric oxide is capable
of inducing intracellular oxidizing reaction and cell death
[16]. Thus, correction of the oxidant/antioxidant imbal-
ance in I/R rats is an important approach to reducing
the risk of developing acute kidney failure.
Aragno et al: DHEA and renal ischemia/reperfusion 837
This study evaluates the effect of treatment with dehy-
droepiandrosterone (DHEA) on oxidative damage and
renal dysfunction in a model of monolateral renal I/R.
DHEA, a multifunctional steroid secreted by the adrenal
gland and brain [17], can protect many tissues against
oxidative damage [18–20]. Its physiologic role is unclear,
although studies show a beneficial effect on vascular func-
tion, atherosclerosis, and complications of diabetes melli-
tus [21–23]. Here, we show that DHEA treatment inter-
feres with the early pro-oxidant responses and with the
TNF- increase caused by I/R, reducing oxidative dam-
age and ameliorating the functionality of the proximal
tubules, the portion most susceptible to injury caused by
I/R [24].
METHODS
Antibodies used in immunoblotting assay were all from
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA).
Unless specifically indicated, all reagents were from
Sigma Chemical Co. (St. Louis, MO, USA).
Treatment of animals
Male Wistar rats (Harlan-Italy, Udine, Italy) weighing
220 to 250 g were cared for in compliance with the Italian
Ministry of Health Guidelines (no. 86/609/EEC) and
with the Principles of Laboratory Animal Care (NIH no.
85-23, revised 1985). They were provided with a pellet
diet (Piccioni no. 48, Gessate Milanese, Italy) and water
ad libitum.
The rats were randomly divided into five groups (N 
8 to 10): (1) control, (2) sham-operated, (3) DHEA
alone, (4) I/R (30 minutes/6 hours), and (5) DHEA plus
I/R. DHEA was given for 21 days at 4 mg/day per rat
before I/R. Crystalline DHEA was dissolved in 1 volume
of 95% ethanol, mixed with 9 volumes mineral oil and
given daily by gastric intubation. Controls received vehi-
cle alone. At the end of the treatment period, rats with
or without DHEA pretreatment were anesthetized and
submitted to transient monolateral renal ischemia. Anes-
thesia was induced with a mixture of Ketavet 100 (Farma-
ceutici Gellini, Ltd., Aprilia, Italy) and Rompum (xilaz-
ina; Bayer AG, Leverkusen, Germany) (4:1, vol/vol) by
intraperitoneal injection (0.5 mL of mixture/200 g body
weight). Body temperature was maintained close to
37.5C to 37.8C with a heating lamp. An abdominal
incision was made and perirenal fat, which supplies small
arteries to the surface of the kidney, was stripped off.
The vascular pedicle of the left kidney was then occluded
with a nontraumatic vascular clamp for 30 minutes. At
the end of this ischemic period, the right kidney was
removed and recirculation of blood flow was established
in the left kidney by releasing the clamp. Reperfusion
was continued for 6 hours, after which the rats were
killed by aortic exsanguination. Sham-operated rats were
subjected to identical surgical procedures except for re-
nal I/R. Blood was collected and the serum isolated.
Ischemic kidney was removed and weighed immediately.
Two coronal sections of approximatively 0.4 cm thick-
ness were cut from the middle portion of the kidney.
One slice was placed in 4% formaldehyde solution in
50 mmol/L phosphate buffer, pH 7.4, for morphologic
studies; the second was immediately frozen under liquid
nitrogen and stored at 80C for immunohistochemical
studies. The rest of the kidney was homogenized in a
Potter Elvejhem device with different procedures.
Isolation of subcellular fractions
An aliquot (1 mL) of kidney homogenate (20%, wt/
vol) prepared in 1.15% KCl was centrifuged at 15,000g
for 18 minutes at 4C; the entire supernatant obtained
was centrifuged at 100,000g for 40 minutes at 4C to
obtain the cytosolic fractions [23]. A second portion of
the kidney was homogenized (20%, wt/vol) in 0.25 mol/L
sucrose, 5 mmol/L Tris-HCl, pH 7.4, medium to prepare
the crude kidney particulate fraction. It was centrifuged
at 1000g for 10 minutes at 4C to remove nuclei and
intact cells, the supernatant fraction (I) being retained;
the pelleted nuclei and intact cells were rehomogenized
with 1 mL of the same medium and centrifuged under
the same conditions to obtain a second supernatant (II).
The two supernatant fractions (I  II) were pooled and
centrifuged at 40,000g for 30 minutes at 4C. The final
pellets were resuspended in fresh homogenising medium
to a final concentration of 1 g equivalent of tissue/millili-
ter and stored at80C (crude particulate fraction) [25].
Pro-oxidant state
The pro-oxidant state was determined by monitoring
generation of hydrogen peroxide (H2O2), adding the fol-
lowings in cuvette (1 mL final volume): 7.4 IU horserad-
ish peroxidase, 40 mol/L acetylated ferrocytochrome-c,
5 mol/L p-hydroxyphenilacetic acid, and 100 L cyto-
solic fractions. H2O2 release was evaluated as the increase
of acetylated ferrocytochrome-c oxidation rate, and moni-
tored at 550 nm minus 540 nm using an absorption coef-
ficient of 19.9 mmol · l1 · cm1, as described by Zoccarato
et al [26]. The nitrite/nitrate concentration in serum was
used as an indicator of nitric oxide synthesis. Nitrates in
serum samples were stoichiometrically reduced to nitrites
by incubation of 250 L of sample for 15 minutes at 37C,
in the presence of 1 IU/mL nitrate reductase, 500 mol/L
nicotinamide adenine dinucleotide phosphate (reduced
form) (NADPH), and 50 mol/L flavin adenine dinucle-
otide (FAD) in a final volume of 400 L. When nitrate
reduction was complete, unused NADPH, which inter-
feres with subsequent nitrite determination, was oxidized
by 100 IU/mL lactate dehydrogenase and 100 mmol/L
sodium pyruvate in a final reaction volume of 500 L
and incubated for 5 minutes at 37C [27]. Subsequently,
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total nitrites in the serum were assayed by adding 500 L
of Griess reagent (4% sulphanilamide and 0.2% naphtylen-
diamide in 10% phosphoric acid) to each sample [28].
Western blot analyses
TNF- and iNOS were detected on cytosolic extracts
using the method of Laemmli [29]. Aliquots of cytosol
containing  60 g proteins were resolved on 7.5% and
on 12% sodium dodecyl sulfate (SDS)-polyacrylamide
gels for TNF- and iNOS, respectively, then blotted onto
nitrocellulose membranes (Amersham Italy; Cologno
Monzese, Milano, Italy). The membranes were blocked
with 5% (wt/vol) nonfat dry milk in 5 mmol/L Tris-HCl,
pH 7.4, containing 200 mmol/L NaCl and 0.05% (vol/vol)
Tween 20 [Tris-buffered saline (TBS)-Tween] for 1 hour
at 25C, then incubated with goat polyclonal antibodies
against TNF- diluted 1:100 or rabbit polyclonal antibod-
ies against iNOS diluted 1:200. The membranes were
incubated with appropriate peroxidase-labeled second-
ary antibody prepared in TBS-Tween containing 2% (wt/
vol) nonfat dry milk. Immunoreactive proteins were de-
tected with the chemiluminescence assay (ECL) (Amer-
sham) and subsequent exposure to film for 2 to 10 min-
utes. Anti--actin antibodies served as loading control
for the cytosolic extract.
Antioxidant enzyme activity in cytosol
Glutathione-peroxidase Se-dependent (GSH-PX) ac-
tivity was assayed by the method described by Flohe`
and Gunzler [30]. A mixture (final volume of 1 mL)
containing 0.6 mol/L EDTA diluted in 6 mmol/L potas-
sium phosphate buffer, pH 7.0, 100L of cytosol (diluted
1:100), 1.37 IU GSH-reductase, 1 mmol/L GSH, and 0.1
mmol/L sodium-azide was incubated for 10 minutes at
37C. After incubation, 0.15 mmol/L NADPH diluted in
0.1% (wt/vol) NaHCO3 was added to the mixture; 0.15
mmol/L H2O2, used as substrate, was then added to start
the reaction. A kinetic analysis at 340 nm was performed
and monitored for three minutes. Catalase activity was
evaluated following the method of Aebi [31]. A mixture
(final volume 3 mL) was directly prepared in cuvette:
1 mL of 30 mmol/L H2O2 diluted in 50 mol/L sodium
phosphate buffer, pH 7.0, and 2 mL of cytosol (diluted
1:100) were monitored at 240 nm for 1 minute. A blank
was prepared for each sample. Cu/Zn superoxide dismu-
tase (SOD) activity was assayed as described by Flohe`
and Otting [32]. A solution (100 mL) was prepared with
5 mmol of xanthine diluted in 0.001 N sodium hydroxide,
2 mmol of cytochrome C, and 50 mmol/L phosphate
buffer, pH 7.8, containing 0.1 mmol/L EDTA; 50 L of
cytosol were added to 2.9 mL of the solution. To start
the reaction, 2.5 IU xanthine oxidase were added to the
prepared mixture and a kinetic analysis was performed
at 550 nm for 3 minutes.
End products of lipid peroxidation
Hydroxynonenal (HNE) concentration was also deter-
mined on fresh cytosolic fractions by the method of Es-
terbauer et al [33]. An aliquot of cytosol (200 L) was
extracted in an equal volume of a solution of acetic
acid:acetonitrile (4:96, vol:vol). After centrifugation at
250g for 20 minutes at 4C, 50 L of supernatant were
injected into a high-performance liquid chromatography
(HPLC) Symmetry C18 column (5 mm, 3.9  150 mm).
The mobile phase used was acetonitrile:bidistilled water
(42%,vol:vol). The HNE concentration was calculated
by comparison with a standard solution of HNE (Calbio-
chem-Novabiochem Corp., La Jolla, CA, USA) of known
concentration.
Functional parameters
Creatinine levels were determined on serum samples
taken 6 hours after reperfusion from the abdominal aorta
artery, using a commercially available kit (Sigma Chemi-
cal Co.). The results are expressed as milligrams per
deciliter.
On crude kidney particulate fraction, Na/K-ATPase
activity was assayed in a medium containing imidazolom-
HCl buffer, pH 7.4, 120 mmol/L NaCl, 10 mmol/L KCl,
5 mmol/L MgCl2, and 4 mmol/L adenosine triphosphate
(ATP). The reaction was started by adding 25 g of
crude particulate protein, and carried out as described
by Shallom and Katayare [34].
Morphologic and immunohistochemical studies
At the end of the reperfusion phase, a coronal section
of the kidney was fixed overnight at 4C in buffered
4% formaldehyde solution, pH 7.4. Paraffin-embedded
sections were prepared and stained with the hematoxy-
lin-eosin technique to evaluate damage of the proximal
convolute tubules. Morphologic changes due to I/R in-
jury were evaluated on 20 proximal tubules from the
superficial and middle cortex using the following scoring
system: 0  normal histology; 1  slight alteration (loss
of brush border, mild hydropic degeneration); 2  mild
(intensive hydropic degeneration, mild vacuolization); 3
moderate (shrunken nuclei, intensive vacuolization); 4
severe (necrotic /apoptotic cells, denudation/rupture of
basement membranes); and 5  necrosis (total necrosis
of the tubule).
Paraffin-embedded sections were prepared from fro-
zen slices of kidney. The sections were deparaffinized,
rehydrated, then immunostained to evaluate the presence
of HNE-protein adducts. For this purpose, sections were
incubated with an anti-HNE hystidine polyclonal anti-
body (Alpha Diagnostic International, San Antonio, TX,
USA) in phosphate-buffered saline (PBS), pH 7.4, con-
taining 1% Tween 20 (vol/vol) and 1% bovine serum
albumin (wt/vol) as described elsewhere [35]. Peroxidase-
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Fig. 1. Level of hydrogen peroxide (H2O2) in kidney cytosolic fraction
and concentration of NO2/NO3 in serum of control rats, dehydroepian-
drosterone (DHEA) (4 mg/21 days), ischemia/reperfusion (I/R), and
DHEA (4 mg/21 days) plus I/R groups. Ischemia lasted 30 minutes,
followed by 6 hours of reperfusion. Data are mean 	 SD (N  8 to
10). *P 
 0.05 vs. control (C); †P 
 0.05 vs. I/R.
linked secondary antibody and diaminobenzidine were
used to detect specific binding. No positive staining was
detected when tissue from the same animals was pro-
cessed without primary antibody, indicating the absence
of nonspecific binding under the conditions applied. The
percentage of tubules with positive immunostaining out
of 100 superficial cortex tubules was calculated.
Statistical analyses
All values in text and figures are expressed as means	
SD of determinations for all rats in the group (N  8
to 10). For histologic scoring, results are expressed as
means	 SEM. Data were analyzed using analysis of vari-
ance (ANOVA) followed by Bonferroni’s post test and
a P value below 0.05 was considered to be significant [36].
RESULTS
Oxidative stress parameters
Monolateral renal I/R (30 minutes/6 hours) determined
a significant increase in pro-oxidant species in kidney tis-
sue. Figure 1 shows high hydrogen peroxide levels in
the cytosol obtained from kidney homogenate and high
serum nitrite/nitrate levels in I/R rats compared with
values for control and sham-operated animals. Sham-
operated rats did not differ from control rats (data there-
fore omitted). The increased levels of both pro-oxidant
species were reduced when DHEA was given for 21 days
prior to I/R.
Cytosolic GSH peroxidase, catalase, and SOD activi-
ties were evaluated as indicators of antioxidant tissue
defenses (Table 1). Renal I/R produced a significant
reduction of all antioxidant enzyme activities analyzed.
When DHEA was administered to rats before I/R, anti-
oxidant activities were normalized.
Cytosolic renal TNF- levels are in Figure 2. I/R rats
showed an increase of cytosolic TNF- levels versus
DHEA plus I/R rats and also versus control rats. TNF-
has been reported to modulate iNOS activity [13]. Figure
2 also reports iNOS levels determined by Western blot
analysis. The iNOS level doubled in I/R rats versus con-
trol rats. In the DHEA plus I/R rats, iNOS was less
expressed (about 70%) than in I/R rats without DHEA.
Moreover, renal I/R caused a significant increase in
the cytosolic concentration of HNE, a toxic end product
of lipid peroxidation, compared to controls (Fig. 3). The
high HNE levels induced by I/R were reduced by DHEA
pretreatment, but DHEA alone did not alter HNE levels
versus control values. No difference was detected be-
tween control and sham-operated rats.
Renal functionality
Rats subjected to I/R showed a significant enhance-
ment in serum creatinine levels compared to control and
sham-operated rats. Renal dysfunction was also con-
firmed by the low Na/K-ATPase activity observed in the
crude particulate fraction (Fig. 4) suggesting an impair-
ment of ATP-dependent activities. Pretreatment with
DHEA significantly reduced creatinine levels in the se-
rum (Fig. 4) and restored ATPase activity to the control
value (Fig. 4). Control and sham-operated rats did not
differ for any of the parameters analyzed.
Morphologic and immunohistochemical studies
After 6 hours of reperfusion, the proximal convoluted
tubules from the superficial and middle cortex showed
different degrees of damage. The average score over 20
tubules was control and sham-operated rats0; DHEA
0; I/R  2.30 	 0.40; and DHEA  I/R  1.90 	 0.10.
DHEA pretreated rats showed a slight, statistically non-
significant reduction of damage versus vehicle-treated
animals (Fig. 5). Intense immunohistochemical staining
for HNE-modified protein was observed in the cytosol
of the damaged epithelial tubular cells after 30 minutes of
ischemia and 6 hours of reperfusion (Fig. 6A). In contrast,
HNE protein was slightly decreased when DHEA was
administered before I/R (Fig. 6B). No HNE-modified
proteins were detected in the sham-operated rats.
DISCUSSION
Renal ischemia followed by reperfusion determines
oxidative stress, as shown by elevated levels of pro-oxi-
dant reactive species and loss of antioxidant systems. In
the kidney of rats subjected to I/R we found an increased
level of H2O2 and reduced antioxidant enzyme activities,
as well as GPX, catalase, and SOD. Moreover, we ob-
served an increase in TNF- and iNOS content, associated
with an increased NO2/NO3 content. This study shows
that DHEA administration completely prevents the
changes in defense antioxidant mechanism and TNF-
and iNOS expression in kidneys of I/R rats, while having
a significant but more limited effect on HNE and renal
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Table 1. Glutathione peroxidase (GSH-PX) catalase and Cu/Zn superoxide-dismutase activities in kidney cytosol of control and
dehydroepiandrosterone (DHEA)-treated rats subjected to ischemia/reperfusion (I/R) (30 minutes/6 hours)
Control DHEA I/R DHEA  I/R
GSH-PX lmol NADPH/min/mg protein 253.0	38.2 272.0	60.8 192.5	7.8a 226.3	28.1b
Catalase nmol/mg protein 3.32	0.27 3.26	0.15 2.53	0.11a 3.34	1.67
Suporoxide dismutase U/mg protein 103.2	2.4 116.2	30.9 47.5	8.9a 102.8	8.0b
Data are mean 	 SD (N  8 to 10).
aP 
 0.05 vs control; bP 
 0.05 vs. I/R
Fig. 2. Western blot of representative experi-
ment showing tumor necrosis factor- (TNF-)
(A) and inducible nitric oxide synthase (iNOS)
(B ) contents in the cytosol of control rats,
dehydroepiandrosterone (DHEA) (4 mg/21
days), ischemia/reperfusion (I/R), and DHEA
(4 mg/21 days) plus I/R groups. Ischemia lasted
30 minutes, followed by 6 hours of reperfu-
sion. The histogram shows the relative densi-
ties of bands compared with -actin. Data are
mean 	 SD of 8 to 10 rats per group.
Na/K-ATPase activity. This different effectiveness on
the various parameters might be due to the specific
DHEA dose used. In view of the chronic clinical use of
DHEA, we treated rats with the lowest DHEA dose
that exerts a significant antioxidant effect [7, 23], consid-
ering that higher doses possess a pro-oxidant effect (pos-
sibly via peroxisomal proliferation) [37, 38].
Oxidative stress increases TNF- production [11],
which, activating nuclear factor-B (NF-B), in turn in-
duces TNF- expression. DHEA can affect TNF- pro-
duction at both levels, since it reduces reactive species
and modulates NF-B activation [7, 23]. TNF-, a pro-
inflammatory cytokine, dramatically induces iNOS mRNA
in epithelial tubular cells, and this is associated with
increased nitric oxide production. Nitric oxide plays an
ambiguous role in I/R tissue. It has been implicated in
the regulation of renal vascular tone and tubular sodium
transport, protecting the ischemic tissue during reperfu-
sion [39, 40]. On the contrary, nitric oxide has also been
found to be directly toxic in isolated rat proximal tubule
segments exposed to hypoxia and reoxygenation [41]
and high levels of nitric oxide have also been observed
in several renal dysfunction models [42]. The deleterious
effect of increased nitric oxide in reperfused kidney
might be greatly enhanced by a simultaneous increase
in superoxide radicals. In the presence of superoxide,
nitric oxide interacts with superoxide to form peroxyni-
trate radicals, an important agent that can cause oxida-
tive and DNA damage [43].
DHEA treatment acts on both nitric oxide production
and on the oxidative balance, thus reducing the forma-
tion of peroxynitrate radicals. The ability of DHEA to
reduce the pro-oxidant species and to restore antioxidant
levels has already been reported [21–23]; DHEA treat-
ment in streptozotocin-treated rats reduces thiobarbi-
turic acid reaction substance and fluorescent chromolipid
and restores glutathione levels in the kidney as well as
the enzymatic activity of catalase, SOD, and glutathione
peroxidase (GSH-PX) [44]. Moreover, when DHEA is
given to diabetic rats subjected to cerebral I/R, it exerts a
beneficial effect against oxidative stress and ameliorates
several markers of neuronal damage induced by free radi-
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Fig. 3. Concentration of hydroxynonenal (HNE) in kidney cytosolic
fraction of control rats, dehydroepiandrosterone (DHEA) (4 mg/21 days),
ischemia/reperfusion (I/R), and DHEA (4 mg/21 days) plus I/R groups.
Ischemia lasted 30 minutes, followed by 6 hours of reperfusion. Data
are means 	 SD (N  8 to 10). *P 
 0.05 vs. control (C); †P 
 0.05
vs. I/R.
Fig. 4. Levels of creatinine in serum and Na/K ATPase activity in
the crude particulate fraction of control rats, dehydroepiandrosterone
(DHEA) (4 mg/21 days), ischemia/reperfusion (I/R), and DHEA (4 mg/
21 days) plus I/R groups. Ischemia lasted 30 minutes, followed by 6
hours of reperfusion. Data are means 	 SD (N  8 to 10). *P 
 0.05
vs. control (C); †P 
 0.05 vs. I/R.
cals [7]. Here we show that besides improving the oxida-
tive balance, DHEA protects lipid membranes against
degradation, as is shown by the reduction in HNE con-
centration as well as by the restoration of Na/K-ATPase
activity. Decreased renal Na/K-ATPase activity has been
found in diabetic rats; I/R likewise reduced Na/K-ATPase
activity, causing a loss membrane exchange functions.
Here we show that DHEA significantly prevents loss of
ATPase activity in I/R rats; we previously observed that
DHEA counteracts the increase of hydroperoxyeicosa-
tetranoic acids (HPETEs) in the kidney of diabetic rats
[22]. HPETEs are potent inhibitors of Na/K-ATPase
activity [45] and contribute to radical mediated kidney
damage. We suggest that, also in I/R, HPETE reduction
induced by DHEA might be one of the mechanisms
involved in protecting Na/K-ATPase activity. Yorek et al
[21] have suggested that DHEA might protect Na/K-
ATPase activity through activation of mitogen-activated
protein kinase and tyrosinase activity [46]. Although this
possibility cannot be ruled out, a direct effect of DHEA
Fig. 5. Morphologic studies of kidney tissue of control rats, dehydroe-
piandrosterone (DHEA) (4 mg/21 days), ischemia/reperfusion (I/R),
and DHEA (4 mg/21 days) plus I/R groups. Ischemia lasted 30 minutes,
followed by 6 hours reperfusion. (A ) Control. (B ) DHEA. (C ) I/R.
(D ) I/RDHEA (hematoxylin-eosin stain,250). (A and B) Compati-
ble with normal histology. (C and D) In contrast with DHEA-treated
rats, the proximal tubules appear more dilatated and cell debris and
cast formation are present in their lumen.
Fig. 6. Immunhistochemistry for hydroxynonenal (HNE) protein ad-
ducts on kidneys submitted to 30 minutes of ischemia followed by 6 hours
of reperfusion. (A ) Ischemia/reperfusion (I/R). (B ) I/R plus dehydro-
epiandrosterone (DHEA)-treated (hematoxylin counterstained, 400).
on Na/K-ATPase protein expression, at the doses used
here, is unlikely since we did not observe any increase
of Na/K-ATPase activity in the nonischemic kidney of
rats treated with DHEA. Serum creatinine is widely used
as a parameter to evaluate both glomerular filtration
and tubular reabsorption. Here the protective effect of
DHEA against I/R injury is confirmed by the improve-
ment of creatinine levels. Furthermore, the DHEA group
showed less evident morphologic damage. Hydropic de-
generation of proximal convolute tubules appears to be
reduced in DHEA pretreated rats. Recent studies indi-
cate that, besides endothelial cells, the tubular epithelial
cells are able to produce large amounts of nitric oxide
[47]. The observed reduction of iNOS expression might
suggest that, also in tubular cells, the decrease of both
reactive nitrogen species and ROS contributes to the
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protective effect of DHEA, reducing the production of
the highly toxic peroxynitrate.
The mechanisms by which DHEA pretreatment pro-
tects the kidney against I/R-induced damage are not
yet fully understood. DHEA becomes effective against
oxidative injury of the brain induced by I/R only after
more than 2 weeks of treatment [23]. One possibility is
that inserting DHEA into the lipid membrane makes it
more resistant to oxidative stress [48]. Intercalation of
DHEA into lipid membranes has been suggested as the
mechanism responsible for the change in shape induced
in vitro by DHEA in human red blood cells. DHEA has
also been reported to change the fatty acid composition
of mytochondrial membrane phospholipids in rats [49].
However, it is also possible to speculate on many other
mechanisms, such as changes in the level of other sub-
stances that attenuate oxidative stress but are yet to be
detected in this role. Modulation of NF-B activation
might play a pivotal role in the protective effect of
DHEA [23]. TNF-/NF-B activation interplay occurs
in oxidative stress [50]. Here we show an important re-
duction of the TNF- level in DHEA-treated rats, thus
TNF-–dependent genes are not activated and tissue
damage is reduced. Moreover, we suggest that another
mechanism known to contribute to oxidative damage
(i.e. peroxynitrite production) may be inhibited by
DHEA [51]. DHEA treatment reduces both radical reac-
tive species and nitric oxide production in I/R and thus
further counteracts oxidative damage. We cannot rule
out that some of the effects of DHEA on kidney injury
and function might be due to its metabolites. Hayashi
et al [52] showed that about 50% of the total antiathero-
sclerosis effect of DHEA (pharmacologic doses that can
give rise to biologically active amounts of estrogens)
depends on estrogens. However, we have observed negli-
gible variations of both 17--estradiol and testosterone
concentrations in rats treated with 4 mg of DHEA [53].
We suggest that estrogen receptors might be directly
activated by DHEA and adiol, as we found in rats bear-
ing 7.12-dimethylbenz(a)anthroacene (DMBA)-induced
mammary tumor [53].
However, the question of whether the effect of DHEA
is due to DHEA itself, to its metabolites, or to a combina-
tion of both is still open, since the relevant molecule(s)
and mechanism(s) are largely unknown. Whatever the
active molecules and mechanisms involved, the data
clearly demonstrate the ability of DHEA pretreatment
in a rat model to reduce renal injury associated to I/R.
These results are of some importance since currently
there is no clinically effective therapy that prevents renal
ischemic injury.
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